This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Familial Aplasia Of The Vermis
Information about Familial Aplasia Of The Vermis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Familial Aplasia Of The Vermis
Most recent studies have shown that Familial Aplasia Of The Vermis shares some biological mechanisms with apnea, ataxia, cerebellar-ataxia, cerebellar-diseases, congenital-abnormality, congenital-absence, cystic-kidney-diseases, developmental-delay-(disorder), developmental-disabilities, dysplasia, eye-abnormalities, hypoplasia, kidney-diseases, meckel-gruber-syndrome, muscle-hypotonia, nephronophthisis, ocular-motility-disorders, polydactyly, respiration-disorders.
Among the many pathways, these few ones have gauged particular interests from scientists studying Familial Aplasia Of The Vermis, and have been seen in publications frequently: Axon Guidance, Brain Development, Brainstem Development, Cell Death, Cell Migration, Cell Proliferation, Central Nervous System Development, Chromosome Segregation, Cognition, Glycosylation, Intraflagellar Transport, Localization, Neurogenesis, Pathogenesis, Phototransduction, Protein Transport, Reflex, Segmentation, Translation, Transport
Quite a number of genes have been found to play important roles in Familial Aplasia Of The Vermis, such as AHI1, ARL13B, CC2D2A, CEP290, INPP5E, INVS, MKKS, MKS1, NPHP1, NPHP4, OFD1, PMPCA, RAB8A, RPGRIP1, RPGRIP1L, SHH, TIMM8A, TMEM216, TMEM67. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.